查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954058

日本準藥品保養護膚市場規模、佔有率、趨勢及預測（依皮膚狀況、成分類型、應用、通路、產品特性及地區分類，2026-2034年）

Japan Medicated Skincare Market Size, Share, Trends and Forecast by Skin Condition, Ingredient Type, Application Type, Distribution Channel, Product Feature, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

日本準藥品護膚市場在2025年達到29.92億美元。 IMARC Group預測，到2034年，該市場規模將達到61.58億美元，2026年至2034年的複合年成長率（CAGR）為8.35%。這一市場成長主要受以下因素的協同效應驅動：,尖端皮膚病學的融合；,皮膚健康日益受到重視；,消費者對針對特定皮膚問題（如痤瘡、色素沉著和敏感肌膚）的產品需求不斷成長。此外，消費者對預防性護膚的意識增強、人口老化以及對經臨床驗證的高品質成分的認可，也推動了準藥品護膚的流行。除了監管部門對準藥品的支持外，國內外品牌基於創新和永續性的競爭也推動了日本準藥品護膚市場佔有率的擴張。

日本準藥品護膚市場趨勢：

消費者信心與法規環境

日本的準藥品護膚產業以厚生勞動省（MHLW）嚴格的法規環境為特徵。宣稱具有療效的產品必須經過嚴格的核准程序，以確保其安全性和有效性。這種嚴格的監管有助於建立消費者信任，日本消費者往往認為「準藥品」比一般化妝品更值得信賴。儘管有許多限制，但憑藉其安全性和品質方面的良好聲譽，擁有強大研發能力的知名品牌依然蓬勃發展。因此，法規環境既保護了消費者權益，也有效阻止了假冒偽劣產品在市場上的氾濫。

科技與個性化的融合

日本準藥妝護膚產業正積極擁抱更多科技進步，以滿足消費者日益成長的個人化護膚產品需求。消費者對針對自身肌膚問題的客製化產品的需求，促使企業將人工智慧 (AI) 和物聯網 (IoT) 技術融入產品之中。這些技術能夠根據特定的肌膚分析結果，打造出個人化的護膚方案，進而提升產品功效和顧客滿意度。此外，家用診斷設備和虛擬護膚課程等美容科技設備的出現，正在重塑消費者的護膚體驗，帶來更具互動性和個人化的護膚流程。這種技術融合不僅滿足了消費者的需求，也使企業在護膚產業的創新中處於領先地位，進一步推動了日本準藥護膚市場的成長。

注重永續性和道德實踐

在消費者日益關注環境和倫理因素的推動下，永續性已成為日本準藥護膚產業的一大趨勢。日本消費者越來越傾向選擇未經動物測試、採用可回收包裝且原料來源符合倫理的產品。為此，護膚品牌積極實踐綠色美容概念，例如開發可重複填充包裝、使用植物來源成分以及減少塑膠廢棄物。這種向永續性的轉變與全球環境目標以及日本消費者重視地球健康的價值觀相契合。因此，致力於永續性的企業能夠在市場競爭中獲得優勢，並吸引更多具有環保意識的消費者。

本報告解答的關鍵問題

  • 日本準藥品護膚市場目前發展狀況如何？您認為未來幾年它將如何發展？
  • 日本準藥品護膚市場如何根據肌膚狀況進行細分？
  • 日本準藥品護膚市場以成分類型分類的市場構成為何？
  • 日本準藥品護膚市場按應用領域分類的詳細情形如何？
  • 日本準藥品護膚市場依通路分類的情況如何？
  • 根據產品特性，日本準藥品護膚市場的市場區隔如何？
  • 日本準藥品護膚市場按地區分類的情況如何？
  • 請介紹日本準藥品護膚市場價值鏈的各個環節。
  • 日本準藥品護膚市場的主要促進因素和挑戰是什麼？
  • 日本準藥品護膚市場的結構是怎麼樣的？主要參與者有哪些？
  • 日本準藥品護膚市場的競爭程度如何？

目錄

第1章：序言

第2章：調查範圍與調查方法

  • 調查目標
  • 相關利益者
  • 數據來源
  • 市場估值
  • 調查方法

第3章執行摘要

第4章：日本準藥品護膚市場概覽

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭資訊

第5章：日本準藥品護膚市場：現狀

  • 過去和當前的市場趨勢（2020-2025）
  • 市場預測（2026-2034）

第6章：日本準藥品保養護膚市場－依皮膚狀況細分

  • 粉刺
  • 濕疹
  • 銀屑病
  • 酒糟
  • 色素沉著

第7章：日本準藥品保養護膚市場－依成分類型細分

  • 抗發炎藥
  • 抗菌劑
  • 抗真菌劑
  • 抗氧化劑
  • 保濕霜

第8章：日本準藥品護膚市場－依應用領域細分

  • 奶油
  • 洗劑
  • 軟膏
  • 凝膠
  • 美容精華液

第9章：日本準藥品保養護膚市場－依銷售管道細分

  • 非處方藥
  • 處方箋
  • 線上零售
  • 藥局
  • 皮膚科診所

第10章：日本準藥品保養護膚市場－依產品特性細分

  • 低過敏性
  • 不致粉刺
  • 無香型
  • 不含對羥基苯甲酸酯
  • 無動物實驗產品

第11章：日本準藥品護膚市場：依地區分類

  • 關東地區
  • 關西、近畿地區
  • 中部地區
  • 九州和沖繩地區
  • 東北部地區
  • 中國地區
  • 北海道地區
  • 四國地區

第12章：日本準藥品護膚市場的競爭格局

  • 概述
  • 市場結構
  • 市場公司定位
  • 關鍵成功策略
  • 競爭對手儀錶板
  • 企業估值象限

第13章主要企業概況

第14章：日本準藥品保養護膚市場：產業分析

  • 促進因素、限制因素和機遇
  • 波特五力分析
  • 價值鏈分析

第15章附錄

簡介目錄
Product Code: SR112026A36778

The Japan medicated skincare market size reached USD 2,992.0 Million in 2025 . Looking forward, IMARC Group expects the market to reach USD 6,158.0 Million by 2034 , exhibiting a growth rate (CAGR) of 8.35% during 2026-2034 . The market is driven primarily by the synergistic mix of cutting-edge dermatological science, vast cultural significance assigned to skin health, and increasing consumer demand for products addressing certain skin conditions such as acne, hyperpigmentation, and sensitivity. Increasing awareness about preventive skincare, aging population, and acceptance of high-quality clinically proven ingredients have also fortified the popularity of medicated skincare. Regulatory assistance to quasi-drugs, along with competition based on innovation and sustainability from locally and globally available brands are fueling the Japan medicated skincare market share.

JAPAN MEDICATED SKINCARE MARKET TRENDS:

Consumer Confidence and Regulatory Environment

Japan's medicated skincare industry is characterized by its strict regulatory environment, which is governed by the Ministry of Health, Labour and Welfare (MHLW). The products that make therapeutic claims need to go through intense approval procedures, assuring safety and effectiveness. This regulatory stringency encourages consumer confidence, whereby Japanese consumers tend to find "quasi-drugs" more trustworthy than regular cosmetics. Notwithstanding restrictions, well-established brands with strong research and development functions still flourish, based on their brand reputation for safety and quality. The regulatory environment is therefore both a protection for consumers and a barrier to expansion for false products in the market.

Integration of Technology and Personalization

The Japanese medicated skincare industry is moving toward adopting more technological advances to address the increasing need for customized skincare products. The consumers are demanding products suited to their individual skin issues, driving companies to incorporate artificial intelligence (AI) and Internet of Things (IoT) based technologies into products. These technologies allow for the formulation of personalized skincare routines based on specific skin analyses, improving product performance and customer satisfaction. Moreover, the emergence of beauty tech devices, including at-home diagnostic machines and virtual skincare sessions, is rewriting the consumer experience, enhancing skincare routines by making them more interactive and customized. This technological integration satisfies consumer demands and places companies at the cusp of innovation in the world of skincare, which further propels the Japan medicated skincare market growth.

Focus on Sustainability and Ethical Practices

Sustainability is now a key trend in Japan's medicated skincare industry, due to enhanced consumer concern regarding environmental and ethical factors. Consumers in Japan are gravitating toward products that are cruelty-free, employ recyclable packaging, and are made through ethical means of procurement. Skincare brands are embracing green beauty practices in return, such as creating refillable packaging, making use of plant-based ingredients, and reducing plastic waste. This transition toward sustainability is congruent with worldwide environmental objectives while it also coincides with Japanese consumers' values of placing importance on the health of the planet. Consequently, companies that take the commitment to sustainability gain a competitive advantage over others in the marketplace, and attract more environmentally aware consumers.

JAPAN MEDICATED SKINCARE MARKET SEGMENTATION:

Skin Condition Insights:

  • Acne
  • Eczema
  • Psoriasis
  • Rosacea
  • Hyperpigmentation

Ingredient Type Insights:

  • Anti-Inflammatories
  • Antibacterials
  • Antifungals
  • Antioxidants
  • Moisturizers

Application Type Insights:

  • Creams
  • Lotions
  • Ointments
  • Gels
  • Serums

Distribution Channel Insights:

  • Over-The-Counter
  • Prescription
  • Online Retail
  • Pharmacy
  • Dermatologist Clinic

Product Feature Insights:

  • Hypoallergenic
  • Non-Comedogenic
  • Fragrance-Free
  • Paraben-Free
  • Cruelty-Free

Regional Insights:

  • Kanto Region
  • Kansai/Kinki Region
  • Central /Chubu Region
  • Kyushu-Okinawa Region
  • Tohoku Region
  • Chugoku Region
  • Hokkaido Region
  • Shikoku Region
  • The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central /Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

COMPETITIVE LANDSCAPE:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

  • KEY QUESTIONS ANSWERED IN THIS REPORT
  • How has the Japan medicated skincare market performed so far and how will it perform in the coming years?
  • What is the breakup of the Japan medicated skincare market on the basis of skin condition?
  • What is the breakup of the Japan medicated skincare market on the basis of ingredient type?
  • What is the breakup of the Japan medicated skincare market on the basis of application type?
  • What is the breakup of the Japan medicated skincare market on the basis of distribution channel?
  • What is the breakup of the Japan medicated skincare market on the basis of product feature?
  • What is the breakup of the Japan medicated skincare market on the basis of region?
  • What are the various stages in the value chain of the Japan medicated skincare market?
  • What are the key driving factors and challenges in the Japan medicated skincare market?
  • What is the structure of the Japan medicated skincare market and who are the key players?
  • What is the degree of competition in the Japan medicated skincare market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Medicated Skincare Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Medicated Skincare Market Landscape

  • 5.1 Historical and Current Market Trends (2020-2025)
  • 5.2 Market Forecast (2026-2034)

6 Japan Medicated Skincare Market - Breakup by Skin Condition

  • 6.1 Acne
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2020-2025)
    • 6.1.3 Market Forecast (2026-2034)
  • 6.2 Eczema
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2020-2025)
    • 6.2.3 Market Forecast (2026-2034)
  • 6.3 Psoriasis
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2020-2025)
    • 6.3.3 Market Forecast (2026-2034)
  • 6.4 Rosacea
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2020-2025)
    • 6.4.3 Market Forecast (2026-2034)
  • 6.5 Hyperpigmentation
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2020-2025)
    • 6.5.3 Market Forecast (2026-2034)

7 Japan Medicated Skincare Market - Breakup by Ingredient Type

  • 7.1 Anti-Inflammatories
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2020-2025)
    • 7.1.3 Market Forecast (2026-2034)
  • 7.2 Antibacterials
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2020-2025)
    • 7.2.3 Market Forecast (2026-2034)
  • 7.3 Antifungals
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2020-2025)
    • 7.3.3 Market Forecast (2026-2034)
  • 7.4 Antioxidants
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2020-2025)
    • 7.4.3 Market Forecast (2026-2034)
  • 7.5 Moisturizers
    • 7.5.1 Overview
    • 7.5.2 Historical and Current Market Trends (2020-2025)
    • 7.5.3 Market Forecast (2026-2034)

8 Japan Medicated Skincare Market - Breakup by Application Type

  • 8.1 Creams
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2020-2025)
    • 8.1.3 Market Forecast (2026-2034)
  • 8.2 Lotions
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2020-2025)
    • 8.2.3 Market Forecast (2026-2034)
  • 8.3 Ointments
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2020-2025)
    • 8.3.3 Market Forecast (2026-2034)
  • 8.4 Gels
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2020-2025)
    • 8.4.3 Market Forecast (2026-2034)
  • 8.5 Serums
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2020-2025)
    • 8.5.3 Market Forecast (2026-2034)

9 Japan Medicated Skincare Market - Breakup by Distribution Channel

  • 9.1 Over-The-Counter
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2020-2025)
    • 9.1.3 Market Forecast (2026-2034)
  • 9.2 Prescription
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2020-2025)
    • 9.2.3 Market Forecast (2026-2034)
  • 9.3 Online Retail
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2020-2025)
    • 9.3.3 Market Forecast (2026-2034)
  • 9.4 Pharmacy
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2020-2025)
    • 9.4.3 Market Forecast (2026-2034)
  • 9.5 Dermatologist Clinic
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2020-2025)
    • 9.5.3 Market Forecast (2026-2034)

10 Japan Medicated Skincare Market - Breakup by Product Feature

  • 10.1 Hypoallergenic
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2020-2025)
    • 10.1.3 Market Forecast (2026-2034)
  • 10.2 Non-Comedogenic
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2020-2025)
    • 10.2.3 Market Forecast (2026-2034)
  • 10.3 Fragrance-Free
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2020-2025)
    • 10.3.3 Market Forecast (2026-2034)
  • 10.4 Paraben-Free
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2020-2025)
    • 10.4.3 Market Forecast (2026-2034)
  • 10.5 Cruelty-Free
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2020-2025)
    • 10.5.3 Market Forecast (2026-2034)

11 Japan Medicated Skincare Market - Breakup by Region

  • 11.1 Kanto Region
    • 11.1.1 Overview
    • 11.1.2 Historical and Current Market Trends (2020-2025)
    • 11.1.3 Market Breakup by Skin Condition
    • 11.1.4 Market Breakup by Ingredient Type
    • 11.1.5 Market Breakup by Application Type
    • 11.1.6 Market Breakup by Distribution Channel
    • 11.1.7 Market Breakup by Product Feature
    • 11.1.8 Key Players
    • 11.1.9 Market Forecast (2026-2034)
  • 11.2 Kansai/Kinki Region
    • 11.2.1 Overview
    • 11.2.2 Historical and Current Market Trends (2020-2025)
    • 11.2.3 Market Breakup by Skin Condition
    • 11.2.4 Market Breakup by Ingredient Type
    • 11.2.5 Market Breakup by Application Type
    • 11.2.6 Market Breakup by Distribution Channel
    • 11.2.7 Market Breakup by Product Feature
    • 11.2.8 Key Players
    • 11.2.9 Market Forecast (2026-2034)
  • 11.3 Central/ Chubu Region
    • 11.3.1 Overview
    • 11.3.2 Historical and Current Market Trends (2020-2025)
    • 11.3.3 Market Breakup by Skin Condition
    • 11.3.4 Market Breakup by Ingredient Type
    • 11.3.5 Market Breakup by Application Type
    • 11.3.6 Market Breakup by Distribution Channel
    • 11.3.7 Market Breakup by Product Feature
    • 11.3.8 Key Players
    • 11.3.9 Market Forecast (2026-2034)
  • 11.4 Kyushu-Okinawa Region
    • 11.4.1 Overview
    • 11.4.2 Historical and Current Market Trends (2020-2025)
    • 11.4.3 Market Breakup by Skin Condition
    • 11.4.4 Market Breakup by Ingredient Type
    • 11.4.5 Market Breakup by Application Type
    • 11.4.6 Market Breakup by Distribution Channel
    • 11.4.7 Market Breakup by Product Feature
    • 11.4.8 Key Players
    • 11.4.9 Market Forecast (2026-2034)
  • 11.5 Tohoku Region
    • 11.5.1 Overview
    • 11.5.2 Historical and Current Market Trends (2020-2025)
    • 11.5.3 Market Breakup by Skin Condition
    • 11.5.4 Market Breakup by Ingredient Type
    • 11.5.5 Market Breakup by Application Type
    • 11.5.6 Market Breakup by Distribution Channel
    • 11.5.7 Market Breakup by Product Feature
    • 11.5.8 Key Players
    • 11.5.9 Market Forecast (2026-2034)
  • 11.6 Chugoku Region
    • 11.6.1 Overview
    • 11.6.2 Historical and Current Market Trends (2020-2025)
    • 11.6.3 Market Breakup by Skin Condition
    • 11.6.4 Market Breakup by Ingredient Type
    • 11.6.5 Market Breakup by Application Type
    • 11.6.6 Market Breakup by Distribution Channel
    • 11.6.7 Market Breakup by Product Feature
    • 11.6.8 Key Players
    • 11.6.9 Market Forecast (2026-2034)
  • 11.7 Hokkaido Region
    • 11.7.1 Overview
    • 11.7.2 Historical and Current Market Trends (2020-2025)
    • 11.7.3 Market Breakup by Skin Condition
    • 11.7.4 Market Breakup by Ingredient Type
    • 11.7.5 Market Breakup by Application Type
    • 11.7.6 Market Breakup by Distribution Channel
    • 11.7.7 Market Breakup by Product Feature
    • 11.7.8 Key Players
    • 11.7.9 Market Forecast (2026-2034)
  • 11.8 Shikoku Region
    • 11.8.1 Overview
    • 11.8.2 Historical and Current Market Trends (2020-2025)
    • 11.8.3 Market Breakup by Skin Condition
    • 11.8.4 Market Breakup by Ingredient Type
    • 11.8.5 Market Breakup by Application Type
    • 11.8.6 Market Breakup by Distribution Channel
    • 11.8.7 Market Breakup by Product Feature
    • 11.8.8 Key Players
    • 11.8.9 Market Forecast (2026-2034)

12 Japan Medicated Skincare Market - Competitive Landscape

  • 12.1 Overview
  • 12.2 Market Structure
  • 12.3 Market Player Positioning
  • 12.4 Top Winning Strategies
  • 12.5 Competitive Dashboard
  • 12.6 Company Evaluation Quadrant

13 Profiles of Key Players

  • 13.1 Company A
    • 13.1.1 Business Overview
    • 13.1.2 Products Offered
    • 13.1.3 Business Strategies
    • 13.1.4 SWOT Analysis
    • 13.1.5 Major News and Events
  • 13.2 Company B
    • 13.2.1 Business Overview
    • 13.2.2 Products Offered
    • 13.2.3 Business Strategies
    • 13.2.4 SWOT Analysis
    • 13.2.5 Major News and Events
  • 13.3 Company C
    • 13.3.1 Business Overview
    • 13.3.2 Products Offered
    • 13.3.3 Business Strategies
    • 13.3.4 SWOT Analysis
    • 13.3.5 Major News and Events
  • 13.4 Company D
    • 13.4.1 Business Overview
    • 13.4.2 Products Offered
    • 13.4.3 Business Strategies
    • 13.4.4 SWOT Analysis
    • 13.4.5 Major News and Events
  • 13.5 Company E
    • 13.5.1 Business Overview
    • 13.5.2 Products Offered
    • 13.5.3 Business Strategies
    • 13.5.4 SWOT Analysis
    • 13.5.5 Major News and Events

14 Japan Medicated Skincare Market - Industry Analysis

  • 14.1 Drivers, Restraints, and Opportunities
    • 14.1.1 Overview
    • 14.1.2 Drivers
    • 14.1.3 Restraints
    • 14.1.4 Opportunities
  • 14.2 Porters Five Forces Analysis
    • 14.2.1 Overview
    • 14.2.2 Bargaining Power of Buyers
    • 14.2.3 Bargaining Power of Suppliers
    • 14.2.4 Degree of Competition
    • 14.2.5 Threat of New Entrants
    • 14.2.6 Threat of Substitutes
  • 14.3 Value Chain Analysis

15 Appendix